Advanced search
Publication Cover
Modern Rheumatology Volume 30, 2020 - Issue 6
Journal homepage
166
Views
4
CrossRef citations to date
0
Altmetric
Connective tissue diseases and related disorders

Predictive role of laboratory markers and clinical features for recurrent Henoch-Schönlein Purpura in childhood: A study from Turkey

Şule GökçeEge University Faculty of Medicine, Department of Pediatrics, General Pediatrics Unit, Ege University, Bornova, TurkeyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3392-4990
ORCID Icon,
Zafer KurugölEge University Faculty of Medicine, Department of Pediatrics, General Pediatrics Unit, Ege University, Bornova, TurkeyORCID Iconhttp://orcid.org/0000-0002-1721-3534
ORCID Icon,
Güldane KoturoğluEge University Faculty of Medicine, Department of Pediatrics, General Pediatrics Unit, Ege University, Bornova, TurkeyORCID Iconhttp://orcid.org/0000-0002-5509-1558
ORCID Icon &
Aslı AslanEge University Faculty of Medicine, Department of Pediatrics, General Pediatrics Unit, Ege University, Bornova, TurkeyORCID Iconhttp://orcid.org/0000-0002-8187-6412
ORCID Icon
Pages 1047-1052 | Received 26 Jun 2019, Accepted 06 Nov 2019, Published online: 03 Feb 2020

References

  • Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197.
  • Chen O, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schonlein Purpura in children: clinical analysis of 120 cases. Af Hlth Sci. 2013;13:94–9.
  • Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet. 2007;369(9566):976–8.
  • Ozaltin F, Bakkaloglu A, Ozen S, Topaloglu R, Kavak U, Kalyoncu M. The significance of IgA class antineutrophil cytoplamsic antibodies (ANCA) in childhood Henoch-Schonlein purpura. Clin Rheumatol. 2004;23(5):426–9.
  • Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch‐Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90(9):916–20.
  • Tabel Y, Inanc FC, Dogan DG, Elmas AT. Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. Iran J Kidney Dis. 2012;6(4):269–74.
  • Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schonlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci. 2013;59:15–26.
  • Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol. 2006;35(1):56–60.
  • Ekinci RMK, Balci S, Sari Gokay S, Yilmaz HL, Dogruel D, Altintas DU, et al. Do practical laboratory indices predict the outcomes of children withHenoch-Schönlein purpura? Postgraduate Med. 2019;131(4):295–8.
  • Calvo-Río V, Hernández JL, Ortiz-Sanjuán F, Loricera J, Palmou-Fontana N, González-Vela MC, et al. Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center. Medicine. 2016;95(28):e4217.
  • Byun J-W, Song H-J, Kim L, Shin J-H, Choi G-S. Jeong-Hyun Shin, Gwang-seong Choi. Predictive Factors of Relapse in Adult With Henoch-Schönlein Purpura. Am J Dermatopathol. 2012;34(2):139–44.
  • Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol. 2013;25(2):171.
  • Dillon MJ. Henoch-Schönlein purpura: recent advances. Clin Exp Rheumatol. 2007;25:S66–S8.
  • Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35(3):143–53.
  • Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Schonlein purpura in children. J Clin Rheumatol. 2007;13(1):25–8.
  • Lei W-T, Tsai P-L, Chu S-H, Kao Y-H, Lin C-Y, Fang L-C, et al. Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database. Pediatr Rheumatol. 2018;16(1):25.
  • Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798–806.
  • Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of renal involvement or relapsing disease in children with Henoch–Schönlein purpura. Rheumatol Int. 2005;25(1):45–8.
  • Alfredo CS, Nunes NA, Len CA, Barbosa CM, Terreri MT, Hilário MO. Henoch-Schönlein purpura: recurrence and chronicity. J Pediatr. 2007;83(2):177–80.
  • Nathwani D, Laing R, Smith CC, Edward N. Recurrent post-infective Henoch- Schönlein syndrome: a genetic influence related to HLA B35? J Infect. 1992;25(2):205–10.
  • García-Porrúa C, González-Louzao C, Llorca J, González-Gay MA. Predictive factors for renal sequelae in adults with Henoch-Schönlein purpura. J Rheumatol. 2001;28(5):1019–24.
  • Calvino MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA. Henoch-Schönlein Purpura in Children from Northwestern Spain: A 20-Year Epidemiologic and Clinical Study. Medicine. 2001;80:279–90.
  • Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensitivity vasculitis and Henoch–Schonlein purpura: a comparison between the 2 disorders. J Rheumatol. 1992;19(5):721–8.
  • Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch–Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.